Physiologically responsive gene therapy (Q45889739)

17 December 2017

review article

1 reference

title

Physiologically responsive gene therapy (English)

1 reference

17 December 2017

0 references

Varley AW

1

1 reference

17 December 2017

Munford RS

series ordinal

2

1 reference

17 December 2017

publication date

1 October 1998

1 reference

17 December 2017

Trends in Molecular Medicine

published in

1 reference

17 December 2017

volume

4

1 reference

17 December 2017

issue

10

1 reference

17 December 2017

page(s)

445-451

1 reference

17 December 2017

Efficient transgene regulation from a single tetracycline-controlled positive feedback regulatory system

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901333-1

7 January 2021

Modified steroid receptors and steroid-inducible promoters as genetic switches for gene therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901333-1

7 January 2021

Chimeric receptors as gene switches

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901333-1

7 January 2021

A two-component expression system that responds to inflammatory stimuli in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901333-1

7 January 2021

Regulation of the acute phase response by cytokines

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901333-1

7 January 2021

Inflammation-induced recombinant protein expression in vivo using promoters from acute-phase protein genes

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901333-1

7 January 2021

The Tat protein of HIV-1 induces tumor necrosis factor-alpha production. Implications for HIV-1-associated neurological diseases

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901333-1

7 January 2021

The expression of the interleukin 6 gene is induced by the human immunodeficiency virus 1 TAT protein

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901333-1

7 January 2021

HIV-1 Tat potentiates TNF-induced NF-kappa B activation and cytotoxicity by altering the cellular redox state

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901333-1

7 January 2021

Activation of the major immediate early gene of human cytomegalovirus by cis-acting elements in the promoter-regulatory sequence and by virus-specific trans-acting components

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901333-1

7 January 2021

A very strong enhancer is located upstream of an immediate early gene of human cytomegalovirus

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901333-1

7 January 2021

Glucose-stimulated genes and prospects of gene therapy for type I diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901333-1

7 January 2021

Glucose responsiveness of a reporter gene transduced into hepatocytic cells using a retroviral vector.

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901333-1

7 January 2021

Regulated production of mature insulin by non-beta-cells.

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901333-1

7 January 2021

Enhancement of glucose-induced insulin secretion in transgenic mice overexpressing human VIP gene in pancreatic beta cells.

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901333-1

7 January 2021

Stable expression of manganese superoxide dismutase (MnSOD) in insulinoma cells prevents IL-1beta- induced cytotoxicity and reduces nitric oxide production

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901333-1

7 January 2021

A gene therapy approach to regulated delivery of erythropoietin as a function of oxygen tension

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901333-1

7 January 2021

Regulated expression of a foreign gene targeted to the ischaemic myocardium

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901333-1

7 January 2021

Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor alpha (cA2) versus placebo in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901333-1

7 January 2021

Amelioration of collagen-induced arthritis by CD95 (Apo-1/Fas)-ligand gene transfer.

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901333-1

7 January 2021

Suppression of collagen-induced arthritis through adenovirus-mediated transfer of a modified tumor necrosis factor alpha receptor gene

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901333-1

7 January 2021

Suppression of experimental arthritis by gene transfer of interleukin 1 receptor antagonist cDNA.

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901333-1

7 January 2021

Prolonged and effective blockade of tumor necrosis factor activity through adenovirus-mediated gene transfer

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901333-1

7 January 2021

Adenovirus-mediated blockade of tumor necrosis factor in mice protects against endotoxic shock yet impairs pulmonary host defense

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901333-1

7 January 2021

The pancreatitis-associated protein I promoter allows targeting to the pancreas of a foreign gene, whose expression is up-regulated during pancreatic inflammation.

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901333-1

7 January 2021

Gene therapy -- promises, problems and prospects

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901333-1

7 January 2021

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901333-1

1 reference

7 January 2021

Therapeutic uses of microencapsulated genetically engineered cells.

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901333-1

7 January 2021

Engineering tissue-specific expression of a recombinant adenovirus: selective transgene transcription in the pancreas using the amylase promoter

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901333-1

7 January 2021

10.1016/S1357-4310(98)01333-1

Identifiers

DOI

1 reference

17 December 2017

1 reference

17 December 2017